Targeting glucose metabolism: an emerging concept for anticancer therapy.

Area of Science:

• Oncology
• Metabolomics
• Biochemistry

Background:

• High mortality persists for advanced and metastatic cancers despite therapeutic advances.
• Cancer cells exhibit distinct glucose metabolism compared to normal cells, favoring aerobic glycolysis.
• This metabolic reprogramming is crucial for cancer cell survival and proliferation.

Purpose of the Study:

• To review alterations in carbohydrate metabolism in cancer cells.
• To discuss the underlying molecular mechanisms driving these metabolic changes.
• To explore therapeutic opportunities targeting cancer metabolism.

Main Methods:

• Literature review of cancer metabolomics and therapeutic strategies.
• Analysis of molecular mechanisms underlying altered glucose metabolism in cancer.
• Examination of preclinical and clinical data for metabolism-targeting agents.

Main Results:

• Cancer cells preferentially utilize aerobic glycolysis over oxidative phosphorylation.
• Targeting tumor metabolism has demonstrated significant cytotoxicity in preclinical cancer models.
• Several metabolism-targeting agents are advancing through clinical trials.

Conclusions:

• Altered carbohydrate metabolism is a hallmark of cancer, presenting therapeutic vulnerabilities.
• Targeting cancer-specific metabolic pathways, particularly glucose metabolism, holds significant therapeutic potential.
• Further research into cancer metabolomics can lead to novel and effective cancer treatments.